Insider · CIK 0001239746
James A Geraghty
Files at PVLA (PALVELLA THERAPEUTICS, INC.), VYGR (Voyager Therapeutics, Inc.), FULC (Fulcrum Therapeutics, Inc.). First filing Oct 28, 2024, latest Oct 28, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PVLA: PALVELLA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Jun 30, 2025 |
| Jun 3, 2025 | VYGR Voyager Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 4, 2025 |
| Dec 12, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | DDisposition to issuer Series F Preferred Stock, par value $0.001 per share | -1 | $0.01 | $0 | 0 | Dec 12, 2024 |
| Aug 7, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | POpen-market purchase Series F Preferred Stock, par value $0.001 per share | +1 | $1.00 | $1 | 1 | Oct 28, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.